Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration No 333-286431
May 19, 2026
Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration No 333-286431
May 19, 2026
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/13/2024 | $5.00 → $3.50 | Buy → Neutral | ROTH MKM |
FWP - CareCloud, Inc. (0001582982) (Subject)
8-K - CareCloud, Inc. (0001582982) (Filer)
25-NSE - CareCloud, Inc. (0001582982) (Subject)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
Acquisition opens a new growth opportunity, bringing trusted compliance, audit-defense, and regulatory expertise to CareCloud's more than 45,000 providers SOMERSET, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that it has acquired Empower Healthcare & Compliance Partners, LLC ("Empower"), a full-service healthcare compliance and advisory firm. The transaction closed on May 22, 2026, and Empower is now a CareCloud company. Founded by industry veteran Mitchell Brie, CHC, Empower's team of certified coders and credentialed compliance pr
SOMERSET, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions, today provided a recap of its 2026 Analyst Day, held on May 19, 2026, at the Nasdaq MarketSite in Times Square, New York City. The event concluded with CareCloud ringing the Nasdaq Closing Bell in a ceremony broadcast live from Times Square. Held under the theme "Building the AI-Native Healthcare Platform," the Analyst Day brought together equity research analysts, investors, partners, and CareCloud customers for an in-depth look at the Company's AI-driven product roadmap, financial performance,
Company intends to access growth capital opportunistically only at or above $5.00 per share through its existing $60 million ATM facility SOMERSET, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD), ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced the full redemption of 100% of its outstanding 8.75% Series B Preferred Stock, marking a major milestone in the Company's multi-year transformation and capital structure evolution. The redemption was funded through CareCloud's recently secured $50 million credit facility, led by Citizens Bank — one of the nation's largest commercial banks with
ROTH MKM downgraded CareCloud from Buy to Neutral and set a new price target of $3.50 from $5.00 previously
SOMERSET, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions, today provided a recap of its 2026 Analyst Day, held on May 19, 2026, at the Nasdaq MarketSite in Times Square, New York City. The event concluded with CareCloud ringing the Nasdaq Closing Bell in a ceremony broadcast live from Times Square. Held under the theme "Building the AI-Native Healthcare Platform," the Analyst Day brought together equity research analysts, investors, partners, and CareCloud customers for an in-depth look at the Company's AI-driven product roadmap, financial performance,
Strategic leadership alignment positions CareCloud to scale execution, expand margins, and accelerate AI-driven innovation across ambulatory and hospital markets SOMERSET, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), ("CareCloud" or the "Company") a leader in healthcare technology and AI-powered solutions, today announced leadership promotions designed to align the organization for its next phase of growth and to position 2026 as a defining year for enterprise AI innovation across the Company's platform. Effective January 1, 2026, A. Hadi Chaudhry will serve as Chief Strategy Officer, leading CareCloud's enterprise AI vision, platform innovation, and com
Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company's Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2025 Annual Shareholders' Meeting on May 27, 2025, during which shareholders re-elected Anne Busquet, Bill Korn and Lawrence Sharnak for another two-year term. Shareholders also voted to approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's 20
Acquisition opens a new growth opportunity, bringing trusted compliance, audit-defense, and regulatory expertise to CareCloud's more than 45,000 providers SOMERSET, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that it has acquired Empower Healthcare & Compliance Partners, LLC ("Empower"), a full-service healthcare compliance and advisory firm. The transaction closed on May 22, 2026, and Empower is now a CareCloud company. Founded by industry veteran Mitchell Brie, CHC, Empower's team of certified coders and credentialed compliance pr
Capital Structure Simplification, AI Product Strategy, and Path to Sustainable Growth in Focus SOMERSET, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in healthcare technology and AI-powered solutions, today announced it will host its 2026 Analyst Day on Tuesday, May 19, 2026, at the Nasdaq MarketSite in New York City. The event will bring together analysts, investors, customers, and CareCloud leadership to explore the Company's strategic direction, product innovation, and financial performance. Capital Structure Simplification A key highlight will be the most significant simplification of the Company's capital stru
Reaffirms Guidance Following Capital Structure Simplification; Revenue Grows 13% Year-Over-Year SOMERSET, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended March 31, 2026. The Company reaffirmed its previously issued financial guidance following the successful closing of a $50 million credit facility, the announced redemption of 100% of its Series B Preferred Stock, and AI product launches. Together, these milestones mark a pivotal step in C